Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Bone Marrow Transplantation

• Publication date

  1990-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 2310876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrations of chromosome No. 1 in blastic phase of chronic myeloid leukemia.

  2009cited by this paper
• Cytogenetic patterns following bone marrow transplantation for chronic granulocytic leukemia.

  1988cited by this paper
• Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration.

  1988cited by this paper
• Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative Study.

  1987cited by this paper
• Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

  1987cited by this paper
• Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies.

  1987cited by this paper
• Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement.

  1987cited by this paper
• TRIPLE CHIMAERISM AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR PHILADELPHIA CHROMOSOME POSITIVE CHRONIC GRANULOCYTIC LEUKAEMIA

  1987cited by this paper
• Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia.

  1986cited by this paper
• Philadelphia‐positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia

  1986cited by this paper
• Cytogenetic markers in allogeneic bone marrow transplantation.

  1986cited by this paper
• Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial.

  1986cited by this paper
• Radiation damage in patients treated by total-body irradiation, bone marrow grafting, and cyclosporin.

  1986cited by this paper
• The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants

  1986cited by this paper
• Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation

  1985cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.

  1985cited by this paper
• Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.

  1984cited by this paper
• Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.

  1984cited by this paper
• Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin

  1984cited by this paper
• Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.

  1984cited by this paper
• Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

  1983cited by this paper
• Allogenic bone marrow transplantation: current status and future directions.

  1983cited by this paper
• Evidence for a multistep pathogenesis of chronic myelogenous leukemia.

  1981cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Bone-marrow transplantation (first of two parts).

  1975cited by this paper

• Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations

  2021cites this paper
• Chronic myeloid leukemia

  2015cites this paper
• Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

  2010cites this paper
• Cytogenetic evolution patterns in CML post-SCT

  2007cites this paper
• Inv(1)(p22q25) in chronic myeloproliferative disease: constitutional or clonal defect?

  2005cites this paper
• Use of a Interferon for the Treatment of Relapse of Chronic Myelogenous Leukemia in Chronic Phase After Allogeneic Bone Marrow Transplantation

  2003cites this paper
• Cytogenetics of chronic myeloid leukaemia.

  2001cites this paper
• Non‐random involvement of chromosome 13 in patients with persistent or relapsed disease after bone‐marrow transplantation for chronic myeloid leukemia

  2000cites this paper
• Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.

  2000cites this paper
• Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation

  1999cites this paper
• Usefulness of detection of minimal residual disease by ‘hypermetaphase’ fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia

  1997cites this paper
• Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase

  1997cites this paper
• The role of stable chromosome aberrations as biological indicators of radiation effect: studies in patients after total body irradiation and bone marrow transplantation.

  1995cites this paper
• Cytogenetics in the diagnosis of hematologic malignancies.

  1994cites this paper
• Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.

  1994cites this paper
• Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

  1993cites this paper
• Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.

  1993cites this paper
• Comparison of chromosome studies on PHA-stimulated blood and unstimulated bone marrow cells in recipients of lymphocyte depleted grafts using counterflow centrifugation.

  1993cites this paper
• What does one do for the CML patient in relapse after allogeneic bone marrow transplantation?

  1993cites this paper
• Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.

  1992cites this paper
• Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.

  1992cites this paper
• Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.

  1992cites this paper
• Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia.

  1992cites this paper
• Interferon alpha treatment of accelerated-phase chronic myeloid leukemia in relapse after bone marrow transplantation: a case with complete cytogenetic and molecular remission.

  1991cites this paper
• Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T‐cell colonies, myeloid, and erythroid progenitor cells

  1991cites this paper
• Alpha‐2b‐interferon as single therapy for patients with chronic myeloid leukemia relapsing after T‐cell depleted allogeneic bone marrow transplantation

  1990cites this paper